Literature DB >> 24905637

Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.

Jeffrey R Curtis1, Lang Chen, Aseem Bharat, Elizabeth Delzell, Jeffrey D Greenberg, Leslie Harrold, Joel Kremer, Soko Setoguchi, Daniel H Solomon, Fenglong Xie, Huifeng Yun.   

Abstract

OBJECTIVE: Linkages between registries and administrative data may provide a valuable resource for comparative effectiveness research. However, personal identifiers that uniquely identify individuals are not always available. Here we describe methods to link a de-identified arthritis registry and US Medicare data. The linked data set was also used to evaluate the generalizability of the registry to the US Medicare population.
METHODS: Rheumatoid arthritis (RA) patients participating in the Consortium of Rheumatology Researchers of North America (CORRONA) registry were linked to Medicare data restricted to rheumatology claims or claims for RA. Deterministic linkage was performed using age, sex, provider identification number, and geographic location of the CORRONA site. We then searched for visit dates in Medicare matching visit dates in CORRONA, requiring ≥1 exact matching date. Linkage accuracy was quantified as a positive predictive value in a subcohort (n = 1,581) with more precise identifiers.
RESULTS: CORRONA participants with self-reported Medicare (n = 11,001) were initially matched to 30,943 Medicare beneficiaries treated by CORRONA physicians. A total of 8,431 CORRONA participants matched on ≥1 visit; 5,317 matched uniquely on all visits. The number of patients who linked and linkage accuracy (from the subcohort) were high for patients with >2 visits (n = 3,458, 98% accuracy), exactly 2 visits (n = 822, 96% accuracy), and 1 visit (n = 1,037, 79% accuracy) that matched exactly on calendar date. Demographics and comorbidity profiles of registry participants were similar to nonparticipants, except participants were more likely to take disease-modifying antirheumatic drugs and biologic agents.
CONCLUSION: Linkage between a national, de-identified outpatient arthritis registry and Medicare data on multiple nonunique identifiers appears feasible and valid.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24905637      PMCID: PMC4245366          DOI: 10.1002/acr.22377

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  23 in total

1.  Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures.

Authors:  J N Katz; J Barrett; M H Liang; A M Bacon; H Kaplan; R I Kieval; S M Lindsey; W N Roberts; D M Sheff; R T Spencer; A L Weaver; J A Baron
Journal:  Arthritis Rheum       Date:  1997-09

Review 2.  A review of uses of health care utilization databases for epidemiologic research on therapeutics.

Authors:  Sebastian Schneeweiss; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2005-04       Impact factor: 6.437

3.  Medicaid, Medicare, and the Michigan Tumor Registry: a linkage strategy.

Authors:  Cathy J Bradley; Charles W Given; Zhehui Luo; Caralee Roberts; Glenn Copeland; Beth A Virnig
Journal:  Med Decis Making       Date:  2007-07-19       Impact factor: 2.583

4.  Linkage of patient records from disparate sources.

Authors:  Xiaochun Li; Changyu Shen
Journal:  Stat Methods Med Res       Date:  2011-06-10       Impact factor: 3.021

Review 5.  What are pragmatic trials?

Authors:  M Roland; D J Torgerson
Journal:  BMJ       Date:  1998-01-24

6.  Validity of deterministic record linkage using multiple indirect personal identifiers: linking a large registry to claims data.

Authors:  Soko Setoguchi; Ying Zhu; Jessica J Jalbert; Lauren A Williams; Chih-Ying Chen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-04-22

7.  The CORRONA database.

Authors:  J M Kremer
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

8.  American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.

Authors:  Leena G Adhikesavan; Eric D Newman; Mark P Diehl; G Craig Wood; Androniki Bili
Journal:  Arthritis Rheum       Date:  2008-12-15

9.  Linking inpatient clinical registry data to Medicare claims data using indirect identifiers.

Authors:  Bradley G Hammill; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Kevin A Schulman; Lesley H Curtis
Journal:  Am Heart J       Date:  2009-06       Impact factor: 4.749

10.  Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients.

Authors:  Lesley H Curtis; Melissa A Greiner; Bradley G Hammill; Lisa D DiMartino; Alisa M Shea; Adrian F Hernandez; Gregg C Fonarow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-06-09
View more
  30 in total

1.  Data linkages between patient-powered research networks and health plans: a foundation for collaborative research.

Authors:  Abiy Agiro; Xiaoxue Chen; Biruk Eshete; Rebecca Sutphen; Elizabeth Bourquardez Clark; Cristina M Burroughs; W Benjamin Nowell; Jeffrey R Curtis; Sara Loud; Robert McBurney; Peter A Merkel; Antoine G Sreih; Kalen Young; Kevin Haynes
Journal:  J Am Med Inform Assoc       Date:  2019-07-01       Impact factor: 4.497

2.  Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.

Authors:  Leslie R Harrold; Bradley S Stolshek; Sabrina Rebello; David H Collier; Alex Mutebi; Sally W Wade; Wendi Malley; Jeffrey D Greenberg; Carol J Etzel
Journal:  Clin Rheumatol       Date:  2017-03-07       Impact factor: 2.980

3.  Linkage of a Population-Based Cohort With Primary Data Collection to Medicare Claims: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Fenglong Xie; Lisandro D Colantonio; Jeffrey R Curtis; Monika M Safford; Emily B Levitan; George Howard; Paul Muntner
Journal:  Am J Epidemiol       Date:  2016-09-19       Impact factor: 4.897

4.  Physician Prescribing Patterns and Risk of Future Long-Term Opioid Use Among Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study.

Authors:  Yvonne C Lee; Bing Lu; Hongshu Guan; Jeffrey D Greenberg; Joel Kremer; Daniel H Solomon
Journal:  Arthritis Rheumatol       Date:  2020-07       Impact factor: 10.995

Review 5.  Comparative effectiveness research with administrative health data in rheumatoid arthritis.

Authors:  Marie Hudson; Koray Tascilar; Samy Suissa
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

6.  Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study.

Authors:  Cynthia J Larmore; Natalie N Boytsov; Carol L Gaich; Xiang Zhang; Andre B Araujo; Sabrina Rebello; Bob A Salim; George W Reed; Leslie R Harrold
Journal:  Rheumatol Ther       Date:  2018-01-10

Review 7.  Tools and Methods for Real-World Evidence Generation: Pragmatic Trials, Electronic Consent, and Data Linkages.

Authors:  Jeffrey R Curtis; P Jeff Foster; Kenneth G Saag
Journal:  Rheum Dis Clin North Am       Date:  2019-05       Impact factor: 2.670

8.  The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights.

Authors:  Jeffrey R Curtis; Lang Chen; Jeffrey D Greenberg; Leslie Harrold; Meredith L Kilgore; Joel M Kremer; Daniel H Solomon; Huifeng Yun
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-12-28       Impact factor: 2.890

9.  Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.

Authors:  Justin K Owensby; Lang Chen; Ronan O'Beirne; Eric M Ruderman; Leslie R Harrold; Joshua A Melnick; Monika M Safford; Jeffrey R Curtis; Maria I Danila
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07       Impact factor: 4.794

10.  Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States.

Authors:  Jeffrey R Curtis; Fenglong Xie; Shuo Yang; Maria I Danila; Justin K Owensby; Lang Chen
Journal:  J Rheumatol       Date:  2018-11-15       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.